Back to search
Atrial Fibrillation Recurrent
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Atrial Fibrillation Recurrent trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Atrial Fibrillation Recurrent trials you may qualify forAtrial fibrillation (AF) is the cause of 20% of strokes, and the risk of stroke in a person suffering from this arrhythmia increases by 5 times. Ischemic stroke…
The ReMATCH Study is a prospective, single arm, open label, multi-center, study utilizing the FARAPULSE PFA System, including the FARAWAVE and FARAPOINT PFA Cat…
The goal of this observational study is to analyze the predictive value of early recurrence within different time windows for late recurrence, ultimately provid…
Conquer-AF is a prospective, multi-center, interventional, non-randomized clinical study that will enroll up to 400 subjects at up to 30 sites across the United…
Patients with atrial fibrillation (AF) who have had a prior stroke are at very high risk of recurrent ischemic stroke. About 40% of these strokes are due to lar…
The goal of this clinical trial is to investigate the efficacy and safety of Qidong Yixin Granules in preventing recurrence in patients after radiofrequency cat…
The NEXT PULSE study is a pre-market, prospective, multi-center, non-randomized, interventional clinical study. Adult subjects with symptomatic paroxysmal or pe…
The aim of this clinical study is to evaluate the efficacy and tolerability of probiotics on atrial fibrillation recurrence.